Antiplatelet therapy offset the benefits of lowering homocysteine in patients with previous stroke or transient ischemic attack (TIA). Results of a randomised, placebo-controlled, trial

VITATOPS Trial Study Group

    Research output: Contribution to journalAbstract/Meeting Abstract

    Original languageEnglish
    Pages (from-to)17-17
    Number of pages1
    JournalInternational Journal of Stroke
    Volume7
    Publication statusPublished - Sep 2012

    Cite this